SEC Form 4 · accession 0001162194-18-000038
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Khadder
Officer — See Remarks
Period of report
Mar 19, 2018
Accepted (ET)
Mar 21, 2018 · 9:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.33 | Mar 19, 2018 | A | 27,500 | A | — | Mar 19, 2028 | Common Stock | 27,500 | 27,500 | D |
Explanation of responses
- F112/48th of the total number of shares subject to the Option will vest on March 19, 2019 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on March 19, 2022, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date.
Remarks
Senior Vice President, General Counsel, and Corporate Secretary